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Abstract—A simple chemical method to synthesize PMAA 
coated maghemite nanoparticles is described. Monomer 
methacrylic acid molecules were absorbed onto the 
synthesized ferrimagnetic nanoparticles followed by 
polymerization. The carboxylic group of PMAA coating 
allowed surface immobilization of foreign molecules. An anti-
cancer drug was successfully adsorbed onto the PMAA coated 
maghemite nanoparticles for potential targeted drug delivery.  
 
Index terms—PMAA; Maghemite; Nanoparticles; Adsorption; 
Polymerization; Drug 
 
I. INTRODUCTION 
Ferrimagnetic iron oxide nanoparticles, due to high 
saturation magnetization, high magnetic susceptibility and 
low toxicity, are promising candidates for applications 
such as magnetic resonance imaging [1], DNA extraction 
[2] and gene and drug delivery [3-4]. General approach to 
tailor the surface properties of the particles for applications 
can be achieved by coating or encapsulation [5].   
Carboxylic acid group (-COOH) can be used for 
immobilization of oligonucleotides and protein on 
polymeic surface via the covalent bonding [6]. In this 
work, a chemical method was developed to synthesize 
functionalized polymer-coated magnetic nanoparticles. The 
free carboxylic acid group of polymer coating of iron oxide 
nanoparticles provided for surface adsorption of desirable 
molecules for potential applications. Carboplatin, highly 
stable in water, is an anti-cancer drug in the therapy of a 
variety of neoplasm. The adverse side effects of the cancer 
drug include nausea, vomiting and hair loss. Targeted drug 
delivery may enhance the drug efficiency and reduce 
undesirable side effects. In this work Carboplatin was 
adsorbed on the ferrimagnetic nanoparticles with surface 
functionalized carboxylic acid group. The coupling was 
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achieved between the carboxylic acid group of the particle 
coating and the ammonium group of the drug.    
 
II. EXPERIMENTAL METHODS 
Ferrimagnetic iron oxide particles were fabricated 
following a reported method for synthesizing magnetite 
nanoparticles [7]. Aqueous solution of Fe(II)/Fe(III) was 
prepared from FeCl3 and FeCl2·4H2O in acidic condition. 
Precipitation of particles occurred at room temperature 
upon reaction with NaOH.  The colloidal suspension was 
mixed with sodium dodecyl sulfate and MAA in water.  
K2S2O8 was added to the solution and polymerization was 
carried out at 70oC in argon.  
The structure of the synthesized iron oxide particles was 
investigated using x-ray diffraction. The lattice parameter 
and the average crystallite size of particles (with and 
without PMAA coating) were calculated from diffraction 
data. Transmission electron microscopy was used to 
characterize the morphology and the microstructure of the 
particles. The electrokinetic properties (zeta potential) as a 
function of pH were determined. Vibration sample 
magnetometry was also used to measure the magnetic 
properties of the particles. 
The measurement of carboplatin adsorption on the 
synthesized PMAA coated maghemite particles was carried 
out using high performance liquid chromatography 
(HPLC).  
 
III. RESULTS AND DISCUSSION 
Figure 1 (a) and (b) show X-ray diffraction spectra of the 
synthesized iron oxide particles without and with PMAA 
coating, respectively. All detected Bragg peaks were 
assigned to the characteristic peaks of spinel iron oxide, 
indicating both samples did not contain crystalline α-Fe2O3 
and iron hydroxides. The calculated lattice parameter a was 
8.346 Å and 8.344 Å for particles with and without PMAA 
coating, respectively. The known lattice parameters of γ-
Fe2O3 is 8.346 Å, thus both samples could be identified as 
γ-Fe2O3. The average crystallite size from x-ray line 
broadening for both samples was about 9 nm.   
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Figure 1. X-ray diffraction spectra of synthesized γ-Fe2O3 
nanoparticles without (a) and with PMAA coating (b). 
 
The TEM images of PMAA coated and uncoated γ-
Fe2O3 nanoparticles are shown in Fig. 2.  The average 
particle size for both samples was approximately 9 nm, 
consistent with the XRD data.  These results confirmed 
that the synthesized nanoparticles were single crystals.  
 
 
 
 
 
 
 
 
 
 
Figure 2. TEM images of the PMAA uncoated (a) and 
coated γ-Fe2O3 nanoparticle (b). 
 
The zeta potential of the synthesized maghemite 
nanoparticles with and without PMAA coating as a 
function of pH values was analyzed (data not shown).  
After coated with PMAA, the origin of surface charge 
changed to carboxylic acid groups, which can be neutral 
COOH or dissociated to COO-. The pKa (intrinsic acidity 
constant) of PMAA is at pH=3-5 [8]. The observed shift of 
isoelectric point from ~pH 8 for uncoated maghemite 
nanoparticles to ~pH 3.4 for PMAA coated maghemite 
nanoparticles could be explained by the formation of 
PMAA layer on the surface of the maghemite nanoparticle.  
Room temperature hysteresis loops of the PMAA coated 
and uncoated maghemite nanoparticles indicated that both 
samples could be not saturated at applied magnetic field of 
9 T. The magnetization at 9 T for was about 57 emu/g and 
50emu/g for uncoated and coated samples, respectively, 
lower than the reported bulk counterpart (74 emu/g). The 
reduced magnetization could be attributed to the small 
particle surface effect [9].  
The absorption of anti-cancer drug on the PMAA coated 
maghemite nanoparticles was carried out as a function of 
pH. The absorption of drug on the PMAA coated 
maghemite can be attributed to the coupling between COO- 
of PMAA and NH4+ of carboplatin. The highest drug 
loading capacity was obtained at a pH value of ~7. 
Increasing or decreasing the pH value reduced the amount 
of adsorbed drug. It can be understood that the dissociated 
COO- groups of the coated PMAA layer decreased with 
decreasing pH value, whereas the protonated NH4+ groups 
of carboplatin decreased with increasing pH value.  
III. SUMMARY 
In this work, a chemical method was developed to 
fabricate PMAA coated maghemite nanoparticles. The 
approach can be extended to synthesize other polymer-
coated functionalized metallic or ceramic nanoparticles. 
The coated magnetic nanoparticles retained their magnetic 
properties. The anti-caner drug carboplatin was adsorbed 
on the coated polymeric surface via the coupling between 
COO- of PMAA and NH4+ of carboplatin. Using the 
carboxylic moiety as binding site, various functional 
molecules can be immobilized for other potential 
applications. 
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